8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jun 13, 2025 · 1y ago · Accession 0001193125-25-140285
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 8-K
- Filing date
- Jun 13, 2025
- Report date
- Jun 13, 2025
- Document
- d877944d8k.htm
- Size
- 212 KB